Key result
Therapeutic plasma exchange achieved a rapid 78% fall in serum triglyceride levels in a patient with severe hypertriglyceridemia and recurrent acute pancreatitis.
Why the study?
Severe hypertriglyceridemia is associated with an increased risk of cardiovascular disease and acute pancreatitis.
Does therapeutic plasma exchange reduce serum triglyceride levels in patients with severe hypertriglyceridemia and recurrent acute pancreatitis?
Case Report (n=1)
Does therapeutic plasma exchange reduce serum triglyceride levels in patients with severe hypertriglyceridemia and recurrent acute pancreatitis?
Therapeutic plasma exchange can rapidly and safely reduce serum triglyceride levels in patients with severe hypertriglyceridemia and recurrent acute pancreatitis refractory to conventional therapy.
TPE may enable rapid TG reduction in HTG pancreatitis; leaves open efficacy and safety in controlled trials.
Severe hypertriglyceridemia (HTG) is associated with an increased risk of cardiovascular disease and acute pancreatitis. We report the case of a 34-year-old female admitted with complaints of recurrent pancreatitis and triglyceride (TG) levels above 995 mg/dl. The patient was started on therapeutic plasma exchange (TPE) to achieve a rapid fall (78%) in serum TG levels. We conclude that TPE is a safe and quick therapeutic treatment modality for patients with HTG-induced recurrent acute pancreatitis who fail to respond to conventional therapy.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2021) conducted a case report in Severe hypertriglyceridemia with recurrent pancreatitis (n=1). Therapeutic plasma exchange was evaluated on Fall in serum triglyceride levels. Therapeutic plasma exchange achieved a rapid 78% fall in serum triglyceride levels in a patient with severe hypertriglyceridemia and recurrent acute pancreatitis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: